Synbiotic SE
A vertically integrated European group in the cannabis and industrial hemp markets.
SBX | F
Overview
Corporate Details
- ISIN(s):
- DE000A351MG9 (+6 more)
- LEI:
- 48510041U2G1IWA3R418
- Country:
- Germany
- Address:
- Münsterstr. 336, 40470 Düsseldorf
- Website:
- https://www.synbiotic.com/
- Sector:
- Manufacturing
Description
Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-17 17:16 |
SYNBIOTIC SE: DURCHFUHRUNG EINER KAPITALERHOHUNG BESCHLOSSEN
|
German | 7.2 KB | ||
| 2025-12-16 11:49 |
Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
|
English | 9.9 KB | ||
| 2025-12-12 13:45 |
SYNBIOTIC SE: Bushdoctor GmbH beantragt Insolvenzverfahren
|
German | 6.7 KB | ||
| 2025-12-11 15:46 |
SYNBIOTIC SE: DURCHFUHRUNG EINER KAPITALERHOHUNG BESCHLOSSEN
|
German | 7.1 KB | ||
| 2025-11-18 10:41 |
SYNBIOTIC strengthens its presence at international events and monitors advance…
|
English | 9.6 KB | ||
| 2025-10-21 10:03 |
SYNBIOTIC welcomes Green Partys proposal for the Industrial Hemp Liberalization…
|
English | 10.3 KB | ||
| 2025-10-10 11:47 |
SYNBIOTIC SE: Anpassung der Umsatz- und Ergebnisprognose fur das Geschaftsjahr …
|
German | 7.4 KB | ||
| 2025-10-02 13:26 |
Positive Outlook: Cannabis Legalization Review and Trumps Endorsement Send Enco…
|
English | 9.2 KB | ||
| 2025-08-14 11:19 |
Across the pond: SYNBIOTIC attracts international investors with established in…
|
English | 10.2 KB | ||
| 2025-07-29 12:54 |
Revenue expected to triple by 2027: Focus on growth markets for medical cannabi…
|
English | 10.9 KB | ||
| 2025-06-11 11:48 |
Successful roadshow continues: SYNBIOTIC keeps expanding its presence in the ca…
|
English | 9.3 KB | ||
| 2025-04-23 09:24 |
SYNBIOTIC SE: HempConsult GmbH, Lending (free of charge) of 50,000 shares as p…
|
English | 6.1 KB | ||
| 2025-04-18 14:14 |
IRIS Capital invests in SYNBIOTIC's growth strategy
|
English | 8.7 KB | ||
| 2025-04-17 13:21 |
SYNBIOTIC SE: STRATEGISCHE PARTNERSCHAFT MIT IRIS CAPITAL INVESTMENT
|
German | 6.8 KB | ||
| 2025-04-01 15:13 |
SYNBIOTIC presents medical cannabis as a pastille for the German market for the…
|
English | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Synbiotic SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Synbiotic SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Synbiotic SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-13 | Otto, Frank | Supervisory board | Other | None | 1,085,723.60 EUR |
| 2023-11-28 | Kruse, Daniel | Other | Buy | None | 19,794.19 EUR |
| 2023-11-28 | Kruse, Daniel | Other | Buy | None | 297.00 EUR |
| 2023-10-23 | Otto, Frank | Supervisory board | Other | None | 354,474.00 EUR |
Peer Companies
